rationale patients severe chronic obstructive pulmonary disease copd varying levels disability despite similar levels lung function variation reflect different copd subtypes different genetic predispositions objectives identify genetic associations phenotypes including measures exercise capacity pulmonary function respiratory symptoms methods NUMBER subjects national emphysema treatment trial genotyped NUMBER markers NUMBER positional biologically plausible candidate genes regression models used test association using approach guard results significant associations effect estimates recalculated using entire cohort positive associations dyspnea confirmed families boston copd study results approach identified epoxide hydrolase ephx1 latent transforming growth binding ltbp4 surfactant protein b sftpb transforming growth tgfb1that associated phenotypes subjects polymorphisms snps ephx1 p NUMBER ltbp4 p NUMBER associated maximal output cardiopulmonary exercise testing markers ltbp4 p NUMBER sftpb p NUMBER associated walk test distance snps ephx1 associated carbon monoxide diffusing capacity p NUMBER snps tgfb1 associated dyspnea p NUMBER replicated family study p NUMBER conclusions polymorphisms genes associated traits fev1 associations identify genes pathways important copd pathogenesis copd related test replication false positive early onset test replication genes microsomal factor beta protein NUMBER factor beta1 copd related single nucleotide NUMBER min copd related